lobbying_activities: 1993426

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1993426	285785fa-2a22-4c14-8566-d39c971e118d	Q2	THE INGRAM GROUP LLC	400577737	ELI LILLY AND COMPANY	2017	second_quarter	PHA	General issues related to the biopharmaceutical and pharmaceutical industries including drug importation. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2017-07-18T17:32:50.617000-04:00